News
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...
US hospitals recommend the MEAL plan for patients taking weight loss medications such as Wegovy and Ozempic Learn how this ...
You have been exercising, eating home-cooked meals, and have managed to cut out fried food and desserts from your diet for ...
A MOTHER has managed to shift over three stone thanks to Mounjaro, but has revealed the five things she wishes she had known ...
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including ...
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
Presented by AstraZeneca{beacon} Health Care Health Care The Big Story CMS targets hospitals with site-neutral drug ruleThe ...
Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results